Most sold healthcare stocks in Q4 2016
See which Healthcare stocks institutional investors trimmed or exited the most in Q4 2016, measured as net reductions in reported share positions from Q3 2016 into Q4 2016. Notable reductions at the top of this list include TEVA PHARMACEUTICAL-SP ADR (TEVA), MERCK & CO. INC. (MRK), ELI LILLY & CO (LLY), BAXTER INTERNATIONAL INC (BAX). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| TEVA | TEVA PHARMACEUTICAL-SP ADR | -14,347,458 | -$735.47M | 1 | 3 | 0 | 1 | 5 |
| MRK | MERCK & CO. INC. | -5,601,598 | -$425.73M | 0 | 5 | 4 | 2 | 13 |
| LLY | ELI LILLY & CO | -4,677,364 | -$391.58M | 0 | 4 | 1 | 1 | 5 |
| BAX | BAXTER INTERNATIONAL INC | -4,155,855 | -$388.79M | 0 | 0 | 6 | 0 | 7 |
| ZTS | ZOETIS INC | -3,126,057 | -$145.69M | 0 | 1 | 2 | 2 | 4 |
| UHS | UNIVERSAL HEALTH SERVICES-B | -1,787,999 | -$227.46M | 0 | 1 | 2 | 0 | 3 |
| DVA | DAVITA INC | -1,757,878 | -$189.90M | 3 | 0 | 1 | 2 | 5 |
| UNH | UNITEDHEALTH GROUP INC | -1,441,619 | $285.58M | 2 | 5 | 7 | 0 | 15 |
| OPK | OPKO HEALTH INC | -1,412,757 | -$14.96M | 0 | 0 | 0 | 1 | 0 |
| ABBV | ABBVIE INC | -1,150,970 | -$73.87M | 2 | 4 | 5 | 0 | 14 |
| RMD | RESMED INC | -1,036,300 | -$68.20M | 0 | 0 | 1 | 0 | 1 |
| PHG | KONINKLIJKE PHILIPS NVR- NY | -953,503 | -$27.43M | 0 | 0 | 2 | 0 | 2 |
| PFE | PFIZER INC | -880,384 | -$63.21M | 1 | 5 | 7 | 0 | 15 |
| HCA | HCA HEALTHCARE INC | -787,132 | -$67.20M | 0 | 1 | 1 | 3 | 2 |
| EW | EDWARDS LIFESCIENCES CORP | -747,917 | -$171.09M | 0 | 0 | 2 | 0 | 2 |
| BKD | BROOKDALE SENIOR LIVING INC | -727,824 | -$22.88M | 0 | 0 | 1 | 1 | 1 |
| NVO | NOVO-NORDISK A/S-SPONS ADR | -705,884 | -$109.36M | 0 | 1 | 1 | 0 | 2 |
| NKTR | NEKTAR THERAPEUTICS | -572,100 | -$9.83M | 0 | 0 | 0 | 1 | 0 |
| EXEL | EXELIXIS INC | -557,940 | -$4.36M | 0 | 0 | 1 | 0 | 1 |
| PTCT | PTC THERAPEUTICS INC | -552,700 | -$7.74M | 0 | 0 | 0 | 1 | 0 |
| GERN | GERON CORP | -515,380 | -$1.19M | 0 | 0 | 0 | 1 | 1 |
| CTLT | CATALENT INC | -489,900 | -$12.66M | 0 | 0 | 0 | 1 | 0 |
| PDCO | PATTERSON COS INC | -484,528 | -$74.58M | 1 | 3 | 1 | 2 | 5 |
| BRKR | BRUKER CORP | -400,800 | -$9.12M | 0 | 0 | 1 | 0 | 1 |
| AMGN | AMGEN INC | -394,875 | -$108.80M | 1 | 2 | 4 | 1 | 10 |
| BIIB | BIOGEN INC | -390,313 | -$223.81M | 2 | 1 | 3 | 2 | 7 |
| PACB | PACIFIC BIOSCIENCES OF CALIF | -374,900 | -$3.36M | 0 | 0 | 0 | 1 | 0 |
| EXAS | EXACT SCIENCES CORP | -365,300 | -$6.78M | 0 | 0 | 0 | 1 | 0 |
| PODD | INSULET CORP | -343,400 | -$14.47M | 0 | 0 | 1 | 0 | 1 |
| LFCR | LIFECORE BIOMEDICAL INC | -337,570 | -$4.21M | 1 | 0 | 1 | 0 | 2 |
| ESPR | ESPERION THERAPEUTICS INC | -318,800 | -$4.42M | 0 | 0 | 0 | 1 | 0 |
| EBS | EMERGENT BIOSOLUTIONS INC | -294,600 | -$8.13M | 0 | 0 | 1 | 0 | 1 |
| PBH | PRESTIGE CONSUMER HEALTHCARE | -288,600 | -$12.43M | 0 | 0 | 1 | 0 | 1 |
| PINC | PREMIER INC-CLASS A | -280,837 | -$12.05M | 1 | 1 | 1 | 0 | 3 |
| SGMO | SANGAMO THERAPEUTICS INC | -272,681 | -$1.77M | 0 | 0 | 1 | 0 | 1 |
| NEO | NEOGENOMICS INC | -251,000 | -$2.06M | 0 | 0 | 0 | 1 | 0 |
| MYGN | MYRIAD GENETICS INC | -229,222 | -$20.57M | 0 | 1 | 1 | 0 | 2 |
| CMRX | CHIMERIX INC | -218,860 | -$1.21M | 0 | 0 | 0 | 1 | 0 |
| CPIX | CUMBERLAND PHARMACEUTICALS | -215,280 | -$58.00K | 0 | 1 | 1 | 0 | 2 |
| VEEV | VEEVA SYSTEMS INC-CLASS A | -210,700 | -$9.81M | 0 | 0 | 1 | 0 | 1 |
| FOLD | AMICUS THERAPEUTICS INC | -196,400 | -$1.45M | 0 | 0 | 0 | 1 | 0 |
| PEN | PENUMBRA INC | -186,500 | -$14.17M | 0 | 0 | 0 | 1 | 0 |
| RGEN | REPLIGEN CORP | -186,100 | -$5.06M | 0 | 0 | 1 | 0 | 1 |
| DHR | DANAHER CORP | -168,713 | -$25.66M | 0 | 5 | 3 | 0 | 9 |
| INVA | INNOVIVA INC | -153,616 | -$7.01M | 0 | 0 | 1 | 0 | 2 |
| EDIT | EDITAS MEDICINE INC | -128,400 | $2.97M | 0 | 0 | 0 | 1 | 1 |
| AXGN | AXOGEN INC | -126,900 | -$1.15M | 0 | 0 | 0 | 1 | 0 |
| ENTA | ENANTA PHARMACEUTICALS INC | -126,629 | $591.00K | 0 | 0 | 1 | 0 | 1 |
| CHE | CHEMED CORP | -114,908 | -$15.21M | 0 | 0 | 1 | 1 | 1 |
| TBRG | TRUBRIDGE INC | -112,000 | -$3.00M | 0 | 0 | 1 | 0 | 1 |
Frequently asked questions about Most sold healthcare stocks in Q4 2016
What are the most sold Healthcare stocks in Q4 2016?
The most sold healthcare stocks in Q4 2016 are those with the largest decrease in reported share counts across institutional investors compared to Q3 2016, based on SEC 13F filings.
Which healthcare stocks did institutional investors trimmed or exited the most in Q4 2016?
Among filers in this sector, net reductions were largest in companies such as TEVA PHARMACEUTICAL-SP ADR (TEVA), MERCK & CO. INC. (MRK), ELI LILLY & CO (LLY), based on aggregated 13F data.
How is institutional selling calculated?
Selling is calculated by summing the net decrease in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q3 2016).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.